U.S. Fertility Diagnostic Market Size, Share & Trends Analysis Report By Procedure Type (X-ray-Based Tubal Patency Testing, Structural & Morphologic Imaging), By Technology Type, By Clinical Setting, By Region, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1 Report Scope & Research Methodology

• 1.1 Market Segmentation
  • 1.1.1 Segment Definition
    • 1.1.1.1 Procedure Type
    • 1.1.1.2 Technology type
    • 1.1.1.3 Clinical setting
• 1.2 Estimates and Forecast Timeline
• 1.3 Research Methodology
  • 1.3.1 Information Procurement
  • 1.3.2 Purchased Database 16
  • 1.3.3 GVR's Internal Database
  • 1.3.4 Secondary Sources
  • 1.3.5 Primary Research
  • 1.3.6 Details Of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Three Pillars of Market Estimation
    • 1.6.1.1 Secondary market research
    • 1.6.1.2 Primary market intelligence
      • 1.6.1.2.1 In-depth interviews (IDIs)
      • 1.6.1.2.2 Online survey program
  • 1.6.2 Market Modeling & Forecasting
    • 1.6.2.1 Model 1: Procedure Type volume analysis
    • 1.6.2.2 Model 2: Technology adoption allocation
    • 1.6.2.3 Model 3: Device utilization modeling
    • 1.6.2.4 Model 4: Revenue estimation (Volume X Price)
    • 1.6.2.5 Top-down validation (Manufacturer revenue benchmarking)
    • 1.6.2.6 CAGR/forecasting calculations & assumptions
      • 1.6.2.6.1 Key forecasting drivers and weights
      • 1.6.2.6.2 Scenario framework (2026 - 2033)
      • 1.6.2.6.3 Factor-based impact assessment
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Research Objectives
  • 1.9.1 Objective - 1
  • 1.9.2 Objective - 2
  • 1.9.3 Objective - 3

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Procedure Type and Technology Type Snapshot
• 2.3 Clinical Setting Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Dynamics
  • 3.1.1 Market Driver Analysis
    • 3.1.1.1 Delayed parenthood and changing demographics
      • 3.1.1.1.1 Case study published by the U.S. Census Bureau in January 2026: Reducing U.S. population growth and its implications for the fertility diagnostic market
    • 3.1.1.2 Rising prevalence of infertility
    • 3.1.1.3 Growth of assisted reproductive technologies (ART)
      • 3.1.1.3.1 Case study published in Gray Local Media Station in February 2026: Expansion of IVF clinics to meet rising ART demand in the U.S.
  • 3.1.2 Market Restraint Analysis
    • 3.1.2.1 High costs and limited reimbursement
    • 3.1.2.2 Technological and data integration challenges
  • 3.1.3 Market Opportunity Analysis
    • 3.1.3.1 At home & point of care diagnostic solutions
    • 3.1.3.2 Expansion of male fertility diagnostics
  • 3.1.4 Market Challenge Analysis
    • 3.1.4.1 Regulatory complexity & approval delays
• 3.2 Fertility Diagnostic Products: Regulatory Framework and Reimbursement Scenario
• 3.3 Technology Landscape
  • 3.3.1 Case study published by the National Library of Medicine in March 2024: accuracy of Hystero-Salpingo-Foam Sonography (Hyfosy) for tubal patency testing
• 3.4 Industry Analysis Tools
  • 3.4.1 Porter's Five Forces Analysis
  • 3.4.2 Pestle Analysis

Chapter 4 U.S. Infertility Market Analysis

• 4.1 U.S. Infertility Market, 2021 - 2033 (USD Billion)
• 4.2 Prevalence/Incidence of Infertility in the U.S., by Gender, 2025
• 4.3 Impact of Infertility Prevalence/Incidence on Demand for Fertility Diagnostics
  • 4.3.1 Case study published by National Library of Medicine: impact of infertility prevalence on demand for fertility diagnostics
  • 4.3.2 Case study published by Raveco Medical in September 2025: importance of early infertility evaluation and its impact on fertility diagnostics demand

Chapter 5 U.S. Fertility Diagnostic Market: TAM, SAM, and SOM Analysis

• 5.1 Total Addressable Market (TAM) Analysis, 2021 to 2033 (USD Billion)
• 5.2 Serviceable Addressable Market (SAM) Analysis, 2021 to 2033 (USD Billion)
• 5.3 Serviceable Obtainable Market (SOM) Analysis, 2021 to 2033 (USD Billion)

Chapter 6 U.S. Fertility Diagnostic Market: Procedure Type Estimates & Trend Analysis

• 6.1 U.S. Fertility Diagnostic Market: Procedure Type Segment Dashboard
• 6.2 Procedure Type Movement & Market Share Analysis, 2025 & 2033
• 6.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Procedure Type, 2021 - 2033 (USD Million)
  • 6.3.1 X-Ray-Based Tubal Patency Testing
    • 6.3.1.1 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
    • 6.3.1.2 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • 6.3.2 Ultrasound-Based Tubal Patency Testing
    • 6.3.2.1 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
    • 6.3.2.2 Ultrasound-based tubal Patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
    • 6.3.2.3 HyCoSy (hysterosalpingo-contrast sonography)
      • 6.3.2.3.1 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
      • 6.3.2.3.2 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual Procedure Type Estimates in Thousands)
    • 6.3.2.4 HyFoSy (hysterosalpingo-foam sonography)
      • 6.3.2.4.1 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
      • 6.3.2.4.2 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
    • 6.3.2.5 Others
      • 6.3.2.5.1 Others market, 2021 - 2033 (USD Million)
      • 6.3.2.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
  • 6.3.3 Proprietary Controlled Contrast Systems
    • 6.3.3.1 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
    • 6.3.3.2 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • 6.3.4 Structural & Morphologic Imaging
    • 6.3.4.1 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
    • 6.3.4.2 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • 6.3.5 Others
    • 6.3.5.1 Others market, 2021 - 2033 (USD Million)
    • 6.3.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)

Chapter 7 U.S. Fertility Diagnostic Market: Technology Type Estimates & Trend Analysis

• 7.1 U.S. Fertility Diagnostic Market: Technology Type Segment Dashboard
• 7.2 Technology Type Movement & Market Share Analysis, 2025 & 2033
• 7.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Technology Type, 2021 - 2033 (USD Million)
  • 7.3.1 X-Ray-Based Technologies
    • 7.3.1.1 X-ray-based technologies market, 2021 - 2033 (USD Million)
  • 7.3.2 Ultrasound-Based Technologies
    • 7.3.2.1 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
  • 7.3.3 Proprietary Diagnostic Devices
    • 7.3.3.1 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)

Chapter 8 U.S. Fertility Diagnostic Market: Clinical Setting Estimates & Trend Analysis

• 8.1 U.S. Fertility Diagnostic Market: Clinical Setting Segment Dashboard
• 8.2 Clinical Setting Movement & Market Share Analysis, 2025 & 2033
• 8.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Clinical Setting, 2021 - 2033 (USD Million)
  • 8.3.1 Fertility & Reproductive Medicine Clinics
    • 8.3.1.1 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
  • 8.3.2 Gynecology / Women's Health Practices
    • 8.3.2.1 Gynecology / women's health practices market, 2021 - 2033 (USD Million)
  • 8.3.3 Radiology & Imaging Centers
    • 8.3.3.1 Radiology & imaging centers market, 2021 - 2033 (USD Million)
  • 8.3.4 Hospital Outpatient Departments
    • 8.3.4.1 Hospital outpatient departments market, 2021 - 2033 (USD Million)
  • 8.3.5 others
    • 8.3.5.1 Others market, 2021 - 2033 (USD Million)

Chapter 9. U.S. Fertility Diagnostic Market: Region Estimates & Trend Analysis

• 9.1 U.S. Fertility diagnostic Market: Region Movement Analysis
• 9.2. U.S. Fertility Diagnostic Market: Region Segment Dashboard
• 9.3. Region Movement & Market Share Analysis, 2025 & 2033
• 9.4. U.S. Fertility Diagnostic Market Estimates & Forecast, by Region
• 9.5. West
  • 9.5.1. West Market, 2021 - 2033 (USD Million)
• 9.6. Southeast
  • 9.6.1. Southeast Market, 2021 - 2033 (USD Million)
• 9.7. Southwest
  • 9.7.1. Southwest Market, 2021 - 2033 (USD Million)
• 9.8. Midwest
  • 9.8.1. Midwest Market, 2021 - 2033 (USD Million)
• 9.9. Northeast
  • 9.9.1. Northeast Market, 2021 - 2033 (USD Million)

Chapter 10 U.S. Fertility Diagnostic Market Competitive Landscape

• 10.1 Participants' Overview
• 10.2 Financial Performance
• 10.3 Product Benchmarking
  • 10.3.1 Gedeon Richter
    • 10.3.1.1. Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3 Product Benchmarking
      • 10.3.1.3.1 Sonography
  • 10.3.2 Femvue (Femasys Inc.)
    • 10.3.2.1. Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3 Product Benchmarking
      • 10.3.2.3.1 Tube testing
  • 10.3.3 Thomas Medical (MedGyn)
    • 10.3.3.1. Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3 Product Benchmarking
      • 10.3.3.3.1 Infertility care
  • 10.3.4 Koninklijke Philips N.V.
    • 10.3.4.1. Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3 Product Benchmarking
      • 10.3.4.3.1 Gynecology ultrasound
  • 10.3.5 Ge Healthcare
    • 10.3.5.1. Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3 Product Benchmarking
      • 10.3.5.3.1 Ultrasound
  • 10.3.6 Samsung Healthcare
    • 10.3.6.1. Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3 Product Benchmarking
      • 10.3.6.3.1 Reproductive endocrinology and infertility
  • 10.3.7 Cooper Surgical, Inc.
    • 10.3.7.1. Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3 Product Benchmarking
      • 10.3.7.3.1. Andrology testing
      • 10.3.7.3.2 Embryo assessment diagnostics
      • 10.3.7.3.3 Hormone & biochemical fertility testing
      • 10.3.7.3.4 Milex support pessaries
  • 10.3.8 Mindray Ds Usa, Inc.
    • 10.3.8.1. Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3 Product Benchmarking
      • 10.3.8.3.1 Ultrasound solutions
      • 10.3.8.3.2 In vitro diagnostics
  • 10.3.9 Vio Healthtech Inc
    • 10.3.9.1 OvuSense tracker
    • 10.3.9.1. Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3 Product Benchmarking
      • 10.3.9.3.1 Ovusensor tracker.
  • 10.3.10 Fujifilm Sonosite, Inc.
    • 10.3.10.1. Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3 Product Benchmarking
      • 10.3.10.3.1 Portable ultrasound machines
  • 10.3.11 Olympus
    • 10.3.11.1. Overview
    • 10.3.11.2. Financial Performance
    • 10.3.11.3 Product Benchmarking
      • 10.3.11.3.1 Microscopes & others
  • 10.3.12 Canon Medical Systems
    • 10.3.12.1. Overview
    • 10.3.12.2. Financial Performance
    • 10.3.12.3 Product Benchmarking
      • 10.3.12.3.1 Ultrasound
  • 10.3.13 Stryker
    • 10.3.13.1. Overview
    • 10.3.13.2. Financial Performance
    • 10.3.13.3 Product Benchmarking
    • 10.3.13.4 Imaging systems
• 10.4 Participant Categorization
• 10.5 Company Market Position Analysis, 2025
• 10.6 Company Market Share Analysis, by Procedure Type, 2025
• 10.7 Strategy Mapping
  • 10.7.1 New Product Launch
  • 10.7.2 Mergers & Acquisitions
  • 10.7.3 Partnership & Collaboration
  • 10.7.4 Market Expansion
  • 10.7.5 Product Approvals

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Percentage of first births, by age of mother: U.S., 2018 - 2023
• Table 4 Annual incidence rates of female infertility diagnoses by age group, active component service women, US armed forces, 2019 - 2023
• Table 5 Common tests for evaluating ovarian reserve and associated costs:
• Table 6 Cost comparison - HyFoSy vs HSG
• Table 7 Notable fertility diagnostic products available in or relevant to the US market
• Table 8 U.S. infertility market, 2021 - 2033 (USD Billion) Total addressable market (TAM) analysis, 2021 to 2033 (USD Billion)
• Table 9 Serviceable addressable market (SAM) analysis, 2021 to 2033 (USD Billion)
• Table 10 Serviceable obtainable market (SOM) analysis, 2021 to 2033 (USD Billion)
• Table 11 U.S. fertility diagnostic market, by procedure type 2021 - 2033 (USD Million)
• Table 12 U.S. fertility diagnostic market, by technology type, 2021 - 2033 (USD Million)
• Table 13 U.S. fertility diagnostic market, by clinical setting, 2021 - 2033 (USD Million)
• Table 14 U.S. fertility diagnostic market revenue estimates and forecast, by region, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 U.S. fertility diagnostic market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. fertility diagnostic market snapshot
• Fig. 9 U.S. fertility diagnostic market: Procedure type, and technology type snapshot
• Fig. 10 U.S. fertility diagnostic market: Clinical setting snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 U.S. fertility diagnostic market dynamics
• Fig. 13 Market driver relevance analysis (Current & future impact)
• Fig. 14 Market restraint relevance analysis (Current & future impact)
• Fig. 15 U.S. fertility diagnostic market: Porter's five forces analysis
• Fig. 16 U.S. fertility diagnostic market: PESTLE analysis
• Fig. 17 Prevalence/incidence of infertility in the US, by gender, 2025 %
• Fig. 18 U.S. fertility diagnostic market: Procedure Type segment dashboard
• Fig. 19 U.S. fertility diagnostic market: Procedure Type market share analysis, 2025 & 2033
• Fig. 20 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
• Fig. 21 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
• Fig. 22 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
• Fig. 23 Ultrasound-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
• Fig. 24 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
• Fig. 25 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
• Fig. 26 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
• Fig. 27 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
• Fig. 28 Other markets, 2021 - 2033 (USD Million)
• Fig. 29 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
• Fig. 30 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
• Fig. 31 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
• Fig. 32 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
• Fig. 33 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousand)
• Fig. 34 Others market, 2021 - 2033 (USD Million)
• Fig. 35 Others market, 2021 - 2033 (Annual procedure type estimates in thousands)
• Fig. 36 U.S. fertility diagnostic market: Technology type segment dashboard
• Fig. 37 U.S. fertility diagnostic market: Technology type market share analysis, 2025 & 2033
• Fig. 38 X-ray-based technologies market, 2021 - 2033 (USD Million)
• Fig. 39 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
• Fig. 40 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)
• Fig. 41 U.S. fertility diagnostic market: Clinical setting segment dashboard
• Fig. 42 U.S. fertility diagnostic market: Clinical setting market share analysis, 2025 & 2033
• Fig. 43 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
• Fig. 44 Gynecology / women's health practices market, 2021 - 2033 (USD Million)
• Fig. 45 Radiology & imaging centers market, 2021 - 2033 (USD Million)
• Fig. 46 Hospital outpatient departments market, 2021 - 2033 (USD Million)
• Fig. 47 Others market, 2021 - 2033 (USD Million)
• Fig. 48 USfertility diagnostic market: Region movement analysis
• Fig. 49 U.S. fertility diagnostic market: Region segment dashboard
• Fig. 50 Northeast market, 2021 - 2033 (USD Million)
• Fig. 51 Southeast market, 2021 - 2033 (USD Million)
• Fig. 52 Southwest market, 2021 - 2033 (USD Million)
• Fig. 53 Midwest market, 2021 - 2033 (USD Million)
• Fig. 54 West market, 2021 - 2033 (USD Million)
• Fig. 55 Company categorization
• Fig. 56 Company market position analysis, 2025
• Fig. 57 Strategy mapping